Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA.
Division of Vascular Surgery, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
J Vasc Surg. 2022 Oct;76(4):1030-1036. doi: 10.1016/j.jvs.2022.03.892. Epub 2022 May 25.
Popliteal artery aneurysms (PAAs) are rare in women, with only ∼5% of all PAAs occurring in women. The aim of the present study was to investigate whether sex disparities exist for patients treated with open PAA repair.
We reviewed all patients with PAAs who had undergone open PAA repair in the Vascular Quality Initiative from January 2010 to July 2021. Univariate analyses and multivariable logistic or Cox regression analyses controlling for potential confounders were performed. The study outcomes included primary patency, major amputation, overall survival, and amputation-free survival at 1 year.
The study included 3807 adult patients, of whom 160 were women (4.2%). The female patients were younger (age, 66.1 years vs 68.3 years; P = .012) and less likely to have coronary artery disease (14.5% vs 23.4%; P = .009). However, the women were more likely to be taking aspirin (69.2% vs 60.4%; P = .019) and statins (67.8% vs 60.4%; P < .001) and to undergo repair for symptomatic disease (77.5% vs 64.1%; P = .001). No difference was found between the women and men in primary patency (95.2% vs 90.8%; P = .230) and overall survival (94.3% vs 96.1%; P = .270). Amputation-free survival was lower for women than for men (91.4% vs 95.3%; P = .033). This finding resulted from by lower freedom from major amputation for women (96.1% vs 98.9%; P = .010). After adjustment for confounders, no differences were found between the women and men regarding the loss of primary patency and all-cause mortality. For symptomatic PAAs, the risk of major amputation was threefold greater for women (adjusted hazard ratio, 3.09; 95% confidence interval, 1.05-9.06; P = .040), and the risk of the composite end point of major amputation or death was twofold higher for women than for men (adjusted hazard ratio, 1.97; 95% confidence interval, 1.02-3.79; P = .043).
In our large national study of patients with PAAs, women were more likely to be treated for symptomatic PAAs. The risk of 1-year major amputation was threefold greater for women with symptomatic PAAs than for men with a similar presentation. Early recognition and treatment of PAAs in women before the PAAs have become symptomatic could optimize limb salvage outcomes in women.
腘动脉动脉瘤(PAAs)在女性中较为罕见,所有 PAAs 中仅有约 5%发生在女性中。本研究旨在探讨接受开放 PAA 修复治疗的患者是否存在性别差异。
我们回顾了 2010 年 1 月至 2021 年 7 月期间在血管质量倡议中接受开放 PAA 修复的所有 PAA 患者。进行了单变量分析和多变量逻辑或 Cox 回归分析,以控制潜在的混杂因素。研究结果包括 1 年时的原发性通畅率、主要截肢率、总生存率和无截肢生存率。
本研究纳入了 3807 例成年患者,其中 160 例为女性(4.2%)。女性患者年龄更小(66.1 岁 vs 68.3 岁;P=0.012),冠心病的可能性更小(14.5% vs 23.4%;P=0.009)。然而,女性更有可能服用阿司匹林(69.2% vs 60.4%;P=0.019)和他汀类药物(67.8% vs 60.4%;P<0.001),并因症状性疾病而接受修复(77.5% vs 64.1%;P=0.001)。女性和男性在原发性通畅率(95.2% vs 90.8%;P=0.230)和总生存率(94.3% vs 96.1%;P=0.270)方面无差异。女性无截肢生存率低于男性(91.4% vs 95.3%;P=0.033)。这一发现源于女性的主要截肢无复发率较低(96.1% vs 98.9%;P=0.010)。在调整混杂因素后,女性和男性在原发性通畅丧失和全因死亡率方面无差异。对于症状性 PAA,女性发生主要截肢的风险是男性的三倍(调整后的危险比,3.09;95%置信区间,1.05-9.06;P=0.040),且女性发生主要截肢或死亡的复合终点的风险是男性的两倍(调整后的危险比,1.97;95%置信区间,1.02-3.79;P=0.043)。
在我们对 PAA 患者的大型全国性研究中,女性更有可能因症状性 PAA 而接受治疗。与表现相似的男性相比,症状性 PAA 女性发生 1 年主要截肢的风险增加了三倍。在 PAA 出现症状之前,早期识别和治疗女性 PAA,可以优化女性的肢体挽救结局。